Healthcare

36

DEDICATED PROFESSIONALS

282

DEALS CLOSED

52

LIVE MANDATES

Oaklins' professionals understand the regulatory, reimbursement, technological, medical and patient environments locally and around the world. We know the key players and can take a global perspective on any M&A deal. We identify the right strategic partners, maximize synergy potential and realize premium valuations for our clients. That's the Oaklins way.

RECENT DEALS
HEALTHCARE

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

KEY SECTOR CONTACTS

Pierre Mathieu

Canada

Partner

VIEW PROFILE

Yves A. Sicard

Canada

Managing Partner

VIEW PROFILE

RECENT OAKLINS
NEWS & PUBLICATIONS

Oaklins’ team in Russia will join SFM Group at the BIO 2017

Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections,…

READ MORE

Globalizing cutting edge technology in point-of-care patient blood management

Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). Read more about the transaction, market trends, deal drivers and M&A valuation aspects.

READ MORE

Shareholder succession at Sphinx Werkzeuge AG

The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro…

READ MORE

Instrumentation Laboratory Acquires CA CASYSO AG, Including TEM® subsidiaries and ROTEM® Testing Systems

Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With…

READ MORE

A new rehabilitation pathway for acquired brain injuries

Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Read more about the transaction, market trends, deal drivers and M&A valuation aspects.

READ MORE

Cross-border deal in biosimilars

HEALTHCARE DEAL FLASH:  Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able…

READ MORE

Consolidation continues in the dental industry

HEALTHCARE DEAL FLASH:  Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions…

READ MORE